Re: Rule 12b-1 Fee Waiver Letter AgreementWaiver Letter Agreement • September 25th, 2020 • John Hancock Strategic Series
Contract Type FiledSeptember 25th, 2020 CompanyWith reference to each of the Distribution Plans entered into by and between John Hancock Investment Management Distributors LLC (formerly, John Hancock Funds, LLC and hereinafter, the “Distributor”) and each of the trusts listed in Appendix A to this letter (each, a “Trust” and collectively, the “Trusts”), on behalf of each of their respective series listed in Appendix A (each, a “Fund” and collectively, the “Funds”), we hereby notify you as follows:
Re: Rule 12b-1 Fee Waiver Letter AgreementWaiver Letter Agreement • September 25th, 2020 • John Hancock Municipal Securities Trust
Contract Type FiledSeptember 25th, 2020 CompanyWith reference to each of the Distribution Plans entered into by and between John Hancock Investment Management Distributors LLC (formerly, John Hancock Funds, LLC and hereinafter, the “Distributor”) and each of the trusts listed in Appendix A to this letter (each, a “Trust” and collectively, the “Trusts”), on behalf of each of their respective series listed in Appendix A (each, a “Fund” and collectively, the “Funds”), we hereby notify you as follows:
Fee Waiver Letter AgreementWaiver Letter Agreement • February 28th, 2017 • Northern Lights Variable Trust
Contract Type FiledFebruary 28th, 2017 CompanyYou have engaged us to act as the investment adviser to each of Power Momentum Index Portfolio (formerly known as JNF SSgA Sector Rotation Portfolio) and Power Dividend Index Portfolio (formerly known as JNF SSgA Tactical Allocation Portfolio) pursuant to an investment advisory agreement, which is subject to the approval of the respective shareholders of each respective portfolio.
Fee Waiver Letter AgreementWaiver Letter Agreement • May 30th, 2017 • Total Income (Plus) Real Estate Fund
Contract Type FiledMay 30th, 2017 CompanyYou have engaged us to act as the investment adviser to the Total Income+ Real Estate Fund pursuant to an Investment Advisory Agreement, which is subject to the approval of the respective shareholders of each respective portfolio.
December 15, 2022 To the Trustees of John Hancock Funds Boston, MA 02116 Re: Rule12b-1 Fee Waiver Letter AgreementWaiver Letter Agreement • September 26th, 2023 • John Hancock Strategic Series
Contract Type FiledSeptember 26th, 2023 CompanyWith reference to each of the Distribution Plans entered into by and between John Hancock Investment Management Distributors LLC (the “Distributor”) and each of the trusts listed in Appendix A to this letter (each, a “Trust” and collectively, the “Trusts”), on behalf of each of their respective series listed in Appendix A (each, a “Fund” and collectively, the “Funds”), we hereby notify you as follows:
Fee Waiver Letter AgreementWaiver Letter Agreement • May 30th, 2017 • Total Income (Plus) Real Estate Fund
Contract Type FiledMay 30th, 2017 Company
WAIVER LETTER AGREEMENT AND SECOND AMENDMENT TO CREDIT AGREEMENT June 17, 2020Waiver Letter Agreement • October 23rd, 2020 • Arch Resources, Inc. • Bituminous coal & lignite surface mining
Contract Type FiledOctober 23rd, 2020 Company IndustryReference is made to that certain Credit Agreement dated April 27, 2017 (as at any time amended, restated, modified or supplemented, the "Credit Agreement"), among ARCH RESOURCES, INC., a Delaware corporation formerly known as Arch Coal, Inc. ("Arch"), the various direct and indirect subsidiaries of Arch identified on the signature pages thereto as "Borrowers" (together with Arch, collectively, "Borrowers", and each individually a "Borrower"), REGIONS BANK, as agent (in its capacity as agent, the "Administrative Agent") for certain financial institutions (collectively, the “Lenders”), and the Lenders. Capitalized terms used herein and not otherwise defined herein shall have the meanings ascribed to such terms in the Credit Agreement.
ContractWaiver Letter Agreement • September 13th, 2023 • Abvc Biopharma, Inc. • Pharmaceutical preparations
Contract Type FiledSeptember 13th, 2023 Company IndustryThis waiver letter agreement (this “Waiver Letter”), to the senior convertible promissory note, dated as of February 23, 2023 (the “Note”), by and between ABVC BioPharma, Inc., a Nevada corporation (the “Company”) and Lind Global Fund II LP, a Delaware limited partnership (“Lind Global”), is made as of September 12, 2023. Unless otherwise indicated, capitalized terms shall have the meanings ascribed to them in the Note.